GSDME and Alzheimer disease: CASP3 exhibits a dual role in AD: it cleaves Gasdermin E to trigger pyroptosis in VSMCs [42] and the subsequent release of pro‐inflammatory cytokines, including IL‐1β [43], while also participating in the apoptotic clearance of damaged cells [44].